LIPELLA PHARMACEUTICALS INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Kaufman Jonathan H | See remarks below. | Purchase | 10,000 | $0.76 | $7,600 | 898,849 | May 14, 2024 |
| Kaufman Jonathan H | See remarks below. | Purchase | 25,000 | $0.87 | $21,750 | 888,849 | Mar 18, 2024 |
| Kaufman Jonathan H | See remarks below. | Award / Grant | 144,906 | $0.69 | $99,985 | 833,849 | Mar 13, 2024 |
| Chancellor Michael B | Chief Medical Officer | Award / Grant | 144,906 | $0.69 | $99,985 | 877,637 | Mar 13, 2024 |
| Chancellor Michael B | Chief Medical Officer | Other | 22,950 | $5.75 | $131,963 | 732,730 | Dec 22, 2022 |